HLB Life Science Co., Ltd. is a pharmaceutical bio company established in 1998 and changed to its current name in 2015. The company focuses on developing global targeted anticancer drugs and has a diversified business portfolio including healthcare, medical devices, and energy businesses.

"HLB Life Science is a research-oriented global targeted anticancer drug development bio-company, leading innovative new drug development through its own R&D capabilities and global partnerships. It is growing into a specialized pharmaceutical bio-company that develops differentiated anticancer new drugs with the goal of extending human life and improving the quality of life."

Business Areas

• Bio-Development Business: We are conducting domestic development and clinical trials of innovative new drug substances such as targeted anticancer drugs Rivoceranib and Pyrotinib, focusing on research and development of biopharmaceuticals.
• Healthcare Business: We provide total solutions in the medical and healthcare fields through the development and manufacturing of in vitro diagnostic medical devices, development of quasi-drug components, and OEM/ODM production of finished products.
• Medical Device Business: We are expanding our business by handling various medical device products, including the manufacturing and sales of disposable syringes and medical consumables, and the development of medical devices made from shape memory alloy materials.

Products

• Targeted Anticancer Drugs (Rivoceranib, Pyrotinib): These are innovative targeted anticancer new drug substances currently undergoing clinical trials for various cancer types, including gastric cancer, liver cancer, and adenoid cystic carcinoma.
• Bio-Artificial Liver (LifeLiver): It is a cell therapy developed to extend the waiting time for liver transplantation in patients with acute liver failure, based on a deep understanding of cells, the fundamental unit of life.
• In Vitro Diagnostic Medical Devices and Medical Consumables: We develop and produce core components for in vitro diagnostic reagents focused on disease prevention, diagnosis, and patient monitoring, as well as various medical consumables such as disposable syringes and alcohol swabs.

Special Notes

• Innovative new drug development capabilities: It possesses a new drug pipeline with global competitiveness, including targeted anticancer drugs such as Rivoceranib and Pyrotinib, and is securing future growth engines through continuous R&D investment.
• Diversified business portfolio: It has established a stable revenue structure through various business divisions such as bio-development, healthcare, medical devices, and energy, and is creating synergy between businesses.
• Aggressive business expansion and investment: It is strengthening its medical device business through the merger with Hwajin Medical and the acquisition of Tinico shares, and enhancing competitiveness through open innovation, such as the introduction of new anticancer drug technology from LSK NRDO.

Recruitment Information

• Main Hiring Positions: We primarily recruit for positions such as bio/pharmaceutical researchers, quality control managers, production/process managers, HR, general affairs, and sales.
• Benefits: We provide retirement pensions, four major insurances, health check-ups, support for various family events, children's tuition fees, condo/resort vouchers, annual and congratulatory/condolence leave, parental leave, welfare mall, education expense support, flexible work system, etc.

💡 A Word from JobPloy
HLB Life Science Co., Ltd. is a bio-company specializing in the development of anticancer new drugs, but it also operates medical device and energy businesses, thus requiring experts in various fields. There may be opportunities for foreign workers in various roles such as R&D, quality control, production, and sales. In particular, if you have an understanding of life sciences and pharmaceuticals and relevant experience, you will be able to contribute significantly to the company.